The association between cannabis use and risk of non-medical pain reliever misuse onset among young adults in a legal cannabis context

被引:2
作者
Rhew, Isaac C. [1 ,3 ]
Le, Vi T. [2 ]
Ramirez, Jason J. [1 ]
Fleming, Charles B. [1 ]
Kilmer, Jason R. [1 ]
Delawalla, Miranda L. M. [1 ]
Hultgren, Brittney A. [1 ]
Lee, Christine M. [1 ]
Larimer, Mary E. [1 ]
Guttmannova, Katarina [1 ]
机构
[1] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA USA
[2] Univ Washington, Social Dev Res Grp, Seattle, WA USA
[3] Univ Washington, Ctr Study Hlth & Risk Behav, Box 357238, Seattle, WA 98195 USA
关键词
Cannabis; Prescription opioid misuse; Young adults; MARIJUANA MOTIVES; UNITED-STATES; HEROIN USE; LEGALIZATION; PREVALENCE; OPIOIDS; LAWS;
D O I
10.1016/j.addbeh.2023.107711
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: Little is known about the prospective relationship between cannabis use and pain reliever misuse. This study examined associations of non-medical and medical cannabis use with onset of non-medical pain re-liever misuse among young adults in Washington State (WA), where non-medical cannabis is legal. Methods: Data were from a cohort-sequential study of adults 18-25 residing in WA. Four annual surveys were used from cohorts recruited in 2014, 2015, and 2016. Participants who had not reported non-medical pain re-liever misuse at baseline were included in discrete time survival analyses (N = 4,236). Odds ratios (ORs) were estimated for new onset of non-medical pain reliever misuse in any given follow-up year over the course of three years according to baseline non-medical and medical cannabis use. Results: When included separately in models, non-medical and medical cannabis use at baseline were associated with increased risk of non-medical pain reliever misuse adjusting for demographic characteristics as well as past year cigarette use and alcohol use (non-medical OR = 5.27; 95 % CI: 3.28, 8.48; medical OR = 2.21; 95 % CI: 1.39, 3.52). Including both forms of use in the model, associations of non-medical and medical cannabis use with non-medical pain reliever misuse onset remained (non-medical OR = 4.64; 95 % CI: 2.88, 7.49; medical OR = 1.65; 95 % CI: 1.04, 2.62). Conclusions: Despite claims that cannabis use may reduce opioid use and related harms, findings suggest that cannabis use, including medical use, may not be protective, but instead may increase risk for non-medical pain reliever misuse.
引用
收藏
页数:5
相关论文
共 40 条
  • [1] [Anonymous], 2017, The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research
  • [2] Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010
    Bachhuber, Marcus A.
    Saloner, Brendan
    Cunningham, Chinazo O.
    Barry, Colleen L.
    [J]. JAMA INTERNAL MEDICINE, 2014, 174 (10) : 1668 - 1673
  • [3] Non-medical use, abuse and dependence on prescription opioids among US adults: Psychiatric, medical and substance use correlates
    Becker, William C.
    Sullivan, Lynn E.
    Tetrault, Jeanette M.
    Desai, Rani A.
    Fiellin, David A.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2008, 94 (1-3) : 38 - 47
  • [4] Qualifying Conditions Of Medical Cannabis License Holders In The United States
    Boehnke, Kevin F.
    Gangopadhyay, Saurav
    Clauw, Daniel J.
    Haffajee, Rebecca L.
    [J]. HEALTH AFFAIRS, 2019, 38 (02) : 295 - 302
  • [5] Opioids for Chronic Noncancer Pain A Systematic Review and Meta-analysis
    Busse, Jason W.
    Wang, Li
    Kamaleldin, Mostafa
    Craigie, Samantha
    Riva, John J.
    Montoya, Luis
    Mulla, Sohail M.
    Lopes, Luciane C.
    Vogel, Nicole
    Chen, Eric
    Kirmayr, Karin
    De Oliveira, Kyle
    Olivieri, Lori
    Kaushal, Alka
    Chaparro, Luis E.
    Oyberman, Inna
    Agarwal, Arnav
    Couban, Rachel
    Tsoi, Ludwig
    Lam, Tommy
    Vandvik, Per Olav
    Hsu, Sandy
    Bala, Malgorzata M.
    Schandelmaier, Stefan
    Scheidecker, Anne
    Ebrahim, Shanil
    Ashoorion, Vahid
    Rehman, Yasir
    Hong, Patrick J.
    Ross, Stephanie
    Johnston, Bradley C.
    Kunz, Regina
    Sun, Xin
    Buckley, Norman
    Sessler, Daniel I.
    Guyatt, Gordon H.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (23): : 2448 - 2460
  • [6] What does the ecological and epidemiological evidence indicate about the potential for cannabinoids to reduce opioid use and harms? A comprehensive review
    Campbell, Gabrielle
    Hall, Wayne
    Nielsen, Suzanne
    [J]. INTERNATIONAL REVIEW OF PSYCHIATRY, 2018, 30 (05) : 91 - 106
  • [7] Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: A natural history study
    Carlson, Robert G.
    Nahhas, Ramzi W.
    Martins, Silvia S.
    Daniulaityte, Raminta
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2016, 160 : 127 - 134
  • [8] The Changing Face of Heroin Use in the United States A Retrospective Analysis of the Past 50 Years
    Cicero, Theodore J.
    Ellis, Matthew S.
    Surratt, Hilary L.
    Kurtz, Steven P.
    [J]. JAMA PSYCHIATRY, 2014, 71 (07) : 821 - 826
  • [9] What Ecologic Analyses Cannot Tell Us About Medical Marijuana Legalization and Opioid Pain Medication Mortality
    Finney, John W.
    Humphreys, Keith
    Harris, Alex H. S.
    [J]. JAMA INTERNAL MEDICINE, 2015, 175 (04) : 655 - +
  • [10] 'Standard THC units': a proposal to standardize dose across all cannabis products and methods of administration
    Freeman, Tom P.
    Lorenzetti, Valentina
    [J]. ADDICTION, 2020, 115 (07) : 1207 - 1216